Perspectives from PD Dr. Susanne Saußele
Universitätsklinikum Mannheim, Germany

• Key criteria for treatment discontinuation
• The impact comorbidity has on TKI decision making
• Additional chromosomal aberrations - considerations in clinical practice
• Highlights of EHA

{rscomments off}